| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $308,024,018 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA298815 | Novel approach to modulate the TME on-demand with therapeutic peptides and proteins. | 000 | 1 | NIH | 7/23/2025 | $615,399 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K08HL181183 | OPTImal vasoPRESsor in persistent pulmonary hypertension of the newborn (OPTIPRES) | 000 | 1 | NIH | 7/23/2025 | $164,916 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AI188897 | Vaccine-mediated cross-alphavirus protection for a live attenuated FDA licensed chikungunya virus vaccine | 000 | 1 | NIH | 7/23/2025 | $3,248,576 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DK124068 | Non-transcriptional regulation of circadian physiology | 001 | 6 | NIH | 7/9/2025 | $48,207 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DK124068 | Non-transcriptional regulation of circadian physiology | 000 | 6 | NIH | 2/26/2025 | $433,865 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA225958 | Novel bioengineered microRNA therapeutics for lung cancer | 001 | 7 | NIH | 7/4/2025 | $394,349 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R13CA306450 | 27th International Conference on Kaposi's Sarcoma associated Herpesvirus and Related Agents | 000 | 1 | NIH | 7/8/2025 | $23,000 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM134859 | Mechanisms of Nuclear Migration | 001 | 6 | NIH | 12/24/2024 | $466,942 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01MH133068 | Brain Aging Across the Lifespan in Neurodevelopmental Disorders | 001 | 2 | NIH | 9/18/2025 | $120,081 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01MH133068 | Brain Aging Across the Lifespan in Neurodevelopmental Disorders | 000 | 2 | NIH | 11/20/2024 | $680,461 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01MH121447 | Genetic Strategies for Neurodevelopmental Research | 000 | 5 | NIH | 12/18/2024 | $535,238 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01GM157739 | Environmental forces shape the ecology of virulent parasites in coastal ecosystems | 000 | 2 | NIH | 8/6/2025 | $685,493 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R33DA059027 | A multi-team system implementation strategy to improve buprenorphine adherence for patients who initiate treatment in the emergency department | 000 | 2 | NIH | 9/10/2025 | $1,156,200 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K23MH141316 | Improving Caregiver Engagement inEarly Interventions for Autistic Children Using a Mobile Health Approach | 000 | 1 | NIH | 9/10/2025 | $191,916 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00CA283299 | Engineering viral nanoparticles for TLR agonist-based multi-functional cancer immunotherapies | 000 | 3 | NIH | 9/11/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01HD114721 | Transitions in the acquisition of language in kids with Down Syndrome | 000 | 1 | NIH | 7/30/2025 | $250,000 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K23HL177334 | Applying digital phenotypes and epigenetics to understand clinical outcomes in acute hypoxemic respiratory failure without acute respiratory distress syndrome (NAHRF) | 000 | 1 | NIH | 7/30/2025 | $169,344 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K99HD119268 | 3D genome-based transcriptional program for male germline differentiation | 000 | 1 | NIH | 7/29/2025 | $128,898 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | RF1MH135390 | Alterations in primate brain development following prenatal immune challenge | 000 | 3 | NIH | 8/5/2025 | $2,401,316 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21AI193999 | Molecular mechanisms underlying persistent effects of early life exposure on lung function and remodeling | 000 | 1 | NIH | 7/23/2025 | $414,368 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AI185685 | Multi Parametric Total-Body Imaging of Immune Activation in Post Acute Sequelae of SARS-CoV-2 (PASC) | 000 | 1 | NIH | 7/30/2025 | $808,672 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01HD114721 | Transitions in the acquisition of language in kids with Down Syndrome | 000 | 1 | NIH | 7/30/2025 | $942,567 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG075827 | Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease | 002 | 4 | NIH | 6/18/2025 | $68,038 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG075827 | Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease | 005 | 4 | NIH | 6/26/2025 | $1,089,452 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG075827 | Integrative genomic, transcriptomic, and proteomic analyses to investigate sex-specific differences in Alzheimer's Disease | 001 | 4 | NIH | 3/13/2025 | $688,507 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K12CA138464 | UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program | 001 | 15 | NIH | 8/7/2025 | $810,000 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM158371 | Physical Biology of the Cellular Glycocalyx | 000 | 1 | NIH | 9/1/2025 | $435,769 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U01NS143225 | Clinical Outcome Assessment and Treatment Monitoring Markers for Clinical Trial Readiness in FXTAS | 000 | 1 | NIH | 7/11/2025 | $1,169,064 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS135005 | The electrical basis of proprioceptive signaling | 001 | 2 | NIH | 4/25/2025 | $476,507 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA240751 | The Impact of Obesity on Radiotherapy Anti-Tumor Effects | 005 | 4 | NIH | 9/17/2025 | $20,883 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA240751 | The Impact of Obesity on Radiotherapy Anti-Tumor Effects | 000 | 4 | NIH | 2/12/2025 | $482,119 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EY026556 | Theranostics of Photoreceptor-RPE-Choroid Neurovascular Unit in Eye Diseases: | 000 | 8 | NIH | 3/14/2025 | $601,113 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | S15OD039782 | Modernization of Anatomical Modeling Capabilities at UC Davis Core Facility | 000 | 1 | NIH | 8/7/2025 | $173,474 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DA056365 | High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction | 000 | 4 | NIH | 2/26/2025 | $487,044 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS144894 | Investigations of Spatial Recognition Memory to Improve Cognitive Outcomes in Epilepsy Surgery | 000 | 1 | NIH | 7/11/2025 | $648,893 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA240751 | The Impact of Obesity on Radiotherapy Anti-Tumor Effects | 002 | 4 | NIH | 5/22/2025 | $53,568 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DA056365 | High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction | 001 | 4 | NIH | 4/10/2025 | $54,117 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS144894 | Investigations of Spatial Recognition Memory to Improve Cognitive Outcomes in Epilepsy Surgery | 001 | 1 | NIH | 8/19/2025 | $11,420 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA240751 | The Impact of Obesity on Radiotherapy Anti-Tumor Effects | 001 | 4 | NIH | 5/2/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS073613 | Molecular-Genetic Dissection of Subcortical Circuitry Regulating Arousal | 001 | 13 | NIH | 7/15/2025 | $44,020 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS073613 | Molecular-Genetic Dissection of Subcortical Circuitry Regulating Arousal | 000 | 13 | NIH | 3/14/2025 | $396,195 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00AG071837 | Regional tau deposition and digital assessment of cognition in preclinical AD and MCI | 000 | 3 | NIH | 8/7/2025 | $244,020 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EB037526 | AI-Driven Digital Pathology Tool for Evaluating Inflammation and Therapeutic Efficacy in Preclinical Models | 000 | 1 | NIH | 7/29/2025 | $705,182 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21NS143088 | Soluble epoxide hydrolase in perinatal brain injury | 000 | 1 | NIH | 8/6/2025 | $442,750 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31AI194664 | Seroepidemiology of Enteric Fever: Advancing Methods to Characterize the Population-Level Force of Infection in a Changing Global Landscape | 002 | 1 | NIH | 9/4/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS144390 | In utero treatment of Dup15q syndrome via lipid nanoparticle based gene editing | 000 | 1 | NIH | 7/31/2025 | $654,339 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K99GM155658 | Investigating the role of the mismatch repair proteins MSH2 and MSH6 in genome stability | 000 | 1 | NIH | 7/28/2025 | $125,000 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31AI194664 | Seroepidemiology of Enteric Fever: Advancing Methods to Characterize the Population-Level Force of Infection in a Changing Global Landscape | 001 | 1 | NIH | 7/22/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00NS133470 | Integration of seasonal cues to modulate neuronal plasticity | 001 | 3 | NIH | 7/31/2025 | -$249,000 |
|
